Evaluates potential associations between the presence of serum antibodies and other histopathologic and clinical features in patients with head and neck squamous cell carcinoma (HNSCC). Proportion of patients with HNSCC who have serum p53 protein; Presence of p53 protein as significantly associated with increased risks of relapse and death.